LU76867A1 - - Google Patents
Info
- Publication number
- LU76867A1 LU76867A1 LU76867A LU76867A LU76867A1 LU 76867 A1 LU76867 A1 LU 76867A1 LU 76867 A LU76867 A LU 76867A LU 76867 A LU76867 A LU 76867A LU 76867 A1 LU76867 A1 LU 76867A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
- C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
- C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7605854A FR2342738A1 (fr) | 1976-03-02 | 1976-03-02 | Nouveaux derives halogenes de la serie du 16a-methyl pregnane |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU76867A1 true LU76867A1 (en:Method) | 1977-09-26 |
Family
ID=9169832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU76867A LU76867A1 (en:Method) | 1976-03-02 | 1977-03-01 |
Country Status (16)
| Country | Link |
|---|---|
| JP (1) | JPS52106855A (en:Method) |
| AT (1) | AT355237B (en:Method) |
| AU (1) | AU509948B2 (en:Method) |
| BE (1) | BE851944A (en:Method) |
| CA (1) | CA1082170A (en:Method) |
| CH (1) | CH619969A5 (en:Method) |
| DE (1) | DE2709078C2 (en:Method) |
| DK (1) | DK156401C (en:Method) |
| FR (1) | FR2342738A1 (en:Method) |
| GB (1) | GB1530975A (en:Method) |
| IE (1) | IE44866B1 (en:Method) |
| LU (1) | LU76867A1 (en:Method) |
| NL (1) | NL7702166A (en:Method) |
| PT (1) | PT66261B (en:Method) |
| SE (1) | SE7702250L (en:Method) |
| ZA (1) | ZA771078B (en:Method) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2462443A1 (fr) * | 1979-07-26 | 1981-02-13 | Roussel Uclaf | Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament |
| FR2533928A1 (fr) * | 1982-10-05 | 1984-04-06 | Roussel Uclaf | Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments |
| DE4433374A1 (de) * | 1994-09-20 | 1996-03-21 | Hoechst Ag | 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB928302A (en) * | 1958-06-20 | 1963-06-12 | Scherico Ltd | í¸-pregnene compounds |
| US3049554A (en) * | 1959-06-01 | 1962-08-14 | Schering Corp | 9, 11-dihalogeno-3, 20-diketopregnanes and processes for their manufacture |
-
1976
- 1976-03-02 FR FR7605854A patent/FR2342738A1/fr active Granted
-
1977
- 1977-02-23 ZA ZA00771078A patent/ZA771078B/xx unknown
- 1977-02-28 JP JP2039977A patent/JPS52106855A/ja active Granted
- 1977-03-01 LU LU76867A patent/LU76867A1/xx unknown
- 1977-03-01 DK DK088277A patent/DK156401C/da not_active IP Right Cessation
- 1977-03-01 NL NL7702166A patent/NL7702166A/xx not_active Application Discontinuation
- 1977-03-01 BE BE175355A patent/BE851944A/xx not_active IP Right Cessation
- 1977-03-01 AT AT136577A patent/AT355237B/de not_active IP Right Cessation
- 1977-03-01 SE SE7702250A patent/SE7702250L/ not_active Application Discontinuation
- 1977-03-01 AU AU22808/77A patent/AU509948B2/en not_active Expired
- 1977-03-01 CA CA272,894A patent/CA1082170A/fr not_active Expired
- 1977-03-02 IE IE462/77A patent/IE44866B1/en unknown
- 1977-03-02 DE DE2709078A patent/DE2709078C2/de not_active Expired
- 1977-03-02 CH CH264177A patent/CH619969A5/fr not_active IP Right Cessation
- 1977-03-02 GB GB8713/77A patent/GB1530975A/en not_active Expired
- 1977-03-02 PT PT66261A patent/PT66261B/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK156401C (da) | 1990-01-08 |
| CA1082170A (fr) | 1980-07-22 |
| PT66261B (fr) | 1979-01-17 |
| DE2709078C2 (de) | 1986-09-11 |
| PT66261A (fr) | 1977-04-01 |
| IE44866L (en) | 1977-09-02 |
| DK88277A (da) | 1977-09-03 |
| AU2280877A (en) | 1978-09-07 |
| ATA136577A (de) | 1979-07-15 |
| AT355237B (de) | 1980-02-25 |
| IE44866B1 (en) | 1982-04-21 |
| JPS6150960B2 (en:Method) | 1986-11-06 |
| BE851944A (fr) | 1977-09-01 |
| AU509948B2 (en) | 1980-06-05 |
| DK156401B (da) | 1989-08-14 |
| GB1530975A (en) | 1978-11-01 |
| SE7702250L (sv) | 1977-09-03 |
| CH619969A5 (en) | 1980-10-31 |
| JPS52106855A (en) | 1977-09-07 |
| ZA771078B (en) | 1978-04-26 |
| FR2342738A1 (fr) | 1977-09-30 |
| NL7702166A (nl) | 1977-09-06 |
| FR2342738B1 (en:Method) | 1979-10-12 |
| DE2709078A1 (de) | 1977-09-08 |